Exatecan Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma

NCT00041236 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

39

Enrollment

NETWORK

Sponsor class

Conditions

Sarcoma

Interventions

DRUG: exatecan mesylate

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC